MedPath
NMPA Approval

Roxatidine Acetate Hydrochloride For Injection

国药准字H20243193

June 4, 2024

Drug Information

注射用盐酸罗沙替丁醋酸酯

注射剂

75mg

化学药品

June 4, 2024

Company Information

Applicant Company

北京市大兴区广平大街9号孵化器大楼8108-8112、8212室

Manufacturing Company

山西省大同经济技术开发区第一医药园区

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

注射用盐酸罗沙替丁醋酸酯 - NMPA 批准文号 | MedPath